Imaging of primary breast cancer with 18F-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour.
Beresford
Mark
M
Marie Curie Research Wing, Mount Vernon Cancer Centre, Northwood, Middlesex, UK. mjberesford@yahoo.co.uk
Sanghera
Bal
B
Wong
Wai-Lup
WL
Makris
Andreas
A
D000368:Aged; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D049109:Cell Proliferation; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D013382:Subtraction Technique; D014057:Tomography, X-Ray Computed / Q000379:methods*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18